Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Data Coming out of the Human Inhibitor PUP Study (HIPS) Reveal 4 Subgroups of Patients with Distinct Antibody Signatures

Blood (2018) 132 (Supplement 1): 3774.

https://doi.org/10.1182/blood-2018-99-115979

Published: 2018

Journal Articles

Ibrutinib Treatment Improves T-Cell Proliferative Ability and Effector Function in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) Patients

Isabelle G. Solman, MS, Marlene Taylor, MS, Hana You, MS, Susan M. O'Brien, MD, Stephen P. Mulligan, PhD FRACP, FRCPA, MBBS, John C. Byrd, MD, James P. Dean, MD PhD, Danelle F. James, MD MAS, Ann Mongan, PhD

Blood (2018) 132 (Supplement 1): 3114.

https://doi.org/10.1182/blood-2018-99-110848

Published: 2018

Journal Articles

Early Enrichment and Subsequent Dysfunction of Marrow ILC Subsets in Monoclonal Gammopathy: Target for IMiD Therapy

Jithendra Kini Bailur, PhD, Sameet Mehta, PhD, Lin Zhang, Natalia Neparidze, MD, Terri L Parker, MD, Noffar Bar, MD, Tara Anderson, PA, Mina Xu, MD, Kavita Dhodapkar, MBBS, Madhav V Dhodapkar, MBBS

Blood (2017) 130 (Supplement 1): 4370.

https://doi.org/10.1182/blood.V130.Suppl_1.4370.4370

Published: 2017

Journal Articles

Longitudinal Antibody Signatures Following FVIII Replacement Therapy in Previously Untreated Patients with Severe Hemophilia Α- New Insights from the Hemophilia Inhibitor PUP Study (HIPS)

Bagirath Gangadharan, PhD, Birgit Reipert, Fritz Scheiflinger, PhD, Joel Bowen, Elizabeth Donnachie, PhD, Karin Fijn van Draat, Ralph A. Gruppo, MD, Jenny Klintman, MD PhD, Christoph Male, MD, Catherine E. McGuinn, MD, Shannon L. Meeks, MD, Michael Recht, MD PhD, Margaret V. Ragni, MD MPH, Hassan M. Yaish, MD, Amy D. Shapiro, MD, Donald L Yee, MD, Vlad Calin Radulescu, MD, Elena Santagostino, Deborah Brown, MD

Blood (2017) 130 (Supplement 1): 88.

https://doi.org/10.1182/blood.V130.Suppl_1.88.88

Published: 2017

Journal Articles

Natural Killer Cells Transfer Antimicrobial and Antitumoral Histone H2AZ to Kill Multiple Myeloma Cells Contributing to Transmissible Cytotoxicity

Beatriz Martin-Antonio, PhD, Guillermo Suñe, PhD, Amer Najjar, PhD, Lorena Perez-Amill, Maria Velasco-de Andres, Francisco Lozano, Ester Lozano, Cristina Muñoz-Punedo, Carlos Fernández de Larrea, Alvaro Urbano-Ispizua, MD PhD

Blood (2016) 128 (22): 2115.

https://doi.org/10.1182/blood.V128.22.2115.2115

Published: 2016

Journal Articles

Immune-Mediated Activation Of Coagulation In Patients With Stevens Johnson Syndrome/Toxic Epidermal Necrolysis

Omer Iqbal, MD, Daneyal Syed, Michael Mosier, MD, Julia Malalis, Christine Mata, Amy Lin, Nicole Mitchel, Schurahazard Abro, Debra Hoppensteadt, Ph.D., Jawed Fareed, Ph.D., Charles Bouchard

Blood (2013) 122 (21): 1117.

https://doi.org/10.1182/blood.V122.21.1117.1117

Published: 2013

Journal Articles

Control of Plasmodium falciparum erythrocytic cycle: γδ T cells target the red blood cell–invasive merozoites

Giulia Costa, Séverine Loizon, Marianne Guenot, Iulia Mocan, Franck Halary, Geneviève de Saint-Basile, Vincent Pitard, Julie Déchanet-Merville, Jean-François Moreau, Marita Troye-Blomberg, Odile Mercereau-Puijalon, Charlotte Behr

Blood (2011) 118 (26): 6952–6962.

https://doi.org/10.1182/blood-2011-08-376111

Published: 2011

Includes: Supplemental data

Journal Articles

Increased HIV-specific CD8 + T-cell cytotoxic potential in HIV elite controllers is associated with T-bet expression

Adam R. Hersperger, Jeffrey N. Martin, Lucy Y. Shin, Prameet M. Sheth, Colin M. Kovacs, Gabriela L. Cosma, George Makedonas, Florencia Pereyra, Bruce D. Walker, Rupert Kaul, Steven G. Deeks, Michael R. Betts

Blood (2011) 117 (14): 3799–3808.

https://doi.org/10.1182/blood-2010-12-322727

Published: 2011

Includes: Supplemental data

Journal Articles

Profiles of Cytotoxic Molecules In Mature NK Cell Neoplasms

Nodoka Sekiguchi, MD, Naoko Asano, MD, Hideki Makishima, MD, PhD, Masanobu Momose, MT, Toshiro Ito, MD, Shigeo Nakamura, MD, Fumihiro Ishida, MD

Blood (2010) 116 (21): 4140.

https://doi.org/10.1182/blood.V116.21.4140.4140

Published: 2010

Journal Articles

Pretreatment Serum Level of 15-KDa Granulysin Might Predict Recurrence and Survival of Diffuse Large B Cell Lymphoma Patients Treated by R-CHOP Regimen

Yong Park, Yoon Ji Choi, Se Jong Park, Se Ryeon Lee, Hwa Jung Sung, Kyong Hwa Park, Seok Jin Kim, MD, PhD, Chul Won Choi, Byung Soo Kim, Kwang Yoon Jung

Blood (2010) 116 (21): 1993.

https://doi.org/10.1182/blood.V116.21.1993.1993

Published: 2010

Journal Articles

Interferon-γ (IFN-γ) Mediates a Direct Fungicidal Effect of Human Natural Killer (NK) Cells Against Aspergillus Fumigatus

Maria Bouzani, Michael Ok, Allison Mc Cormick, Frank Ebel, Hermann Einsele, MD, Juergen Loeffler

Blood (2010) 116 (21): 2779.

https://doi.org/10.1182/blood.V116.21.2779.2779

Published: 2010

Journal Articles

The multifaceted granulysin

Laurence Zitvogel, Guido Kroemer

Blood (2010) 116 (18): 3379–3380.

https://doi.org/10.1182/blood-2010-08-299214

Published: 2010

Journal Articles

Cytotoxic CD4 + T cells use granulysin to kill Cryptococcus neoformans , and activation of this pathway is defective in HIV patients

Chun Fu Zheng, Ling Ling Ma, Gareth J. Jones, M. John Gill, Alan M. Krensky, Paul Kubes, Christopher H. Mody

Blood (2006) 109 (5): 2049–2057.

https://doi.org/10.1182/blood-2006-03-009720

Published: 2006

Journal Articles

Gene Expression Profiles of the Clinically Significant "Late" Stage Expanded Cytotoxic T Cells in Myeloma.

Tetsuo Yamagishi, BSc, Warren Kaplan, PhD, Devanshi Seth, PhD, Shihong Yang, MMed, Xin An, PhD, Ross D. Brown, PhD, Joy Ho, MBBS, John Gibson, MBBS, Douglas E. Joshua, MBBS, Daniel M. Sze, PhD

Blood (2005) 106 (11): 3418.

https://doi.org/10.1182/blood.V106.11.3418.3418

Published: 2005

Journal Articles

Varicella-Zoster-Virus-Specific CD4+ Cytotoxic T Cells as Tumor-Specific Effector Cells in Cancer Immunotherapy.

Silke Landmeier, Sibylle Pscherer, Bodo Eing, MD, Cliona M. Rooney, PhD, Heribert Juergens, MD, Claudia Rossig, MD

Blood (2005) 106 (11): 1292.

https://doi.org/10.1182/blood.V106.11.1292.1292

Published: 2005

Journal Articles

Cytokine production and cytolytic mechanism of CD4 + cytotoxic T lymphocytes in ex vivo expanded therapeutic Epstein-Barr virus–specific T-cell cultures

Qi Sun, Robert L. Burton, Kenneth G. Lucas

Blood (2002) 99 (9): 3302–3309.

https://doi.org/10.1182/blood.V99.9.3302

Published: 2002

NARROW

Data Coming out of the Human Inhibitor PUP Study (HIPS) Reveal 4 Subgroups of Patients with Distinct Antibody Signatures

Ibrutinib Treatment Improves T-Cell Proliferative Ability and Effector Function in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) Patients

Early Enrichment and Subsequent Dysfunction of Marrow ILC Subsets in Monoclonal Gammopathy: Target for IMiD Therapy

Longitudinal Antibody Signatures Following FVIII Replacement Therapy in Previously Untreated Patients with Severe Hemophilia Α- New Insights from the Hemophilia Inhibitor PUP Study (HIPS)

Natural Killer Cells Transfer Antimicrobial and Antitumoral Histone H2AZ to Kill Multiple Myeloma Cells Contributing to Transmissible Cytotoxicity

Immune-Mediated Activation Of Coagulation In Patients With Stevens Johnson Syndrome/Toxic Epidermal Necrolysis

Control of Plasmodium falciparum erythrocytic cycle: γδ T cells target the red blood cell–invasive merozoites

Increased HIV-specific CD8 + T-cell cytotoxic potential in HIV elite controllers is associated with T-bet expression

Profiles of Cytotoxic Molecules In Mature NK Cell Neoplasms

Pretreatment Serum Level of 15-KDa Granulysin Might Predict Recurrence and Survival of Diffuse Large B Cell Lymphoma Patients Treated by R-CHOP Regimen

Interferon-γ (IFN-γ) Mediates a Direct Fungicidal Effect of Human Natural Killer (NK) Cells Against Aspergillus Fumigatus

The multifaceted granulysin

Cytotoxic CD4 + T cells use granulysin to kill Cryptococcus neoformans , and activation of this pathway is defective in HIV patients

Gene Expression Profiles of the Clinically Significant "Late" Stage Expanded Cytotoxic T Cells in Myeloma.

Varicella-Zoster-Virus-Specific CD4+ Cytotoxic T Cells as Tumor-Specific Effector Cells in Cancer Immunotherapy.

Cytokine production and cytolytic mechanism of CD4 + cytotoxic T lymphocytes in ex vivo expanded therapeutic Epstein-Barr virus–specific T-cell cultures

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only